Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry, v3.5.4, was added to the history to replace the previous v3.5.3. This reflects an update to the page's revision record.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history now reflects a newer revision tag, updating from v3.5.2 to v3.5.3. This indicates an updated version of the study record history on the page.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the record history.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 on the Record History page.SummaryDifference0.0%

- Check103 days agoChange DetectedA new revision entry v3.4.2 was added to the history. The funding notice and the previous revision v3.4.1 were removed from the history.SummaryDifference0.4%

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.